Orange Book Blog

At the intersection of Patent and FDA Law

Pharma News Briefs

Bloomberg reports that the topic of reverse payment settlements of Hatch-Waxman litigation came up in a recent Senate hearing.
Bloomberg TV interviewed me yesterday about reverse payment settlements. On Pharma has the video.
DUSA Pharmaceuticals announced that a federal court recently lifted the preliminary injunction that prevented River’s Edge Pharmaceuticals from selling generic Nicomide, a treatment for acne.
Pharmalot has this post on the most recent IMS numbers, which indicate that U.S. prescription drug sales rose 8% last year to $275 billion.